Abstract
We studied both serum-free colony-forming unit-megakaryocyte (CFU-meg) numbers and serum thrombopoietin (TPO) levels in 14 patients with aplastic anemia (AA), 37 patients with myelodysplastic syndromes (MDS) and 23 patients with idiopathic thrombocytopenic purpura (ITP) to assess thrombopoiesis in these thrombocytopenic disorders. The mean CFU-meg numbers were lower in AA and MDS patients (10.7 ± 11.4 and 42.3 ± 58.5/105 BMLD cells) than in healthy controls (103.1 ± 57.3/105 BMLD cells) (P < 0.0001 and P = 0.0053, respectively), although they were distributed variably in MDS. ITP patients showed higher CFU-meg numbers (223.2 ± 143.5/105 BMLD cells) (P = 0.017). The mean TPO concentrations were higher in both AA (986.8 ± 500.8 pg/ml) and MDS patients (838.2 ± 639.1 pg/ml) than in healthy controls (80.7 ± 38.8 pg/ml) (P < 0.0001), although they were distributed from high to low in MDS. ITP patients showed a slight elevation of TPO (123.1 ± 55.3 pg/ml) P = 0.0106). The TPO levels was inversely correlated to both platelet counts and CFU-meg numbers (correlative coefficient (CC): −0.719 and −0.682, P < 0.0001) in AA, but not in ITP. In MDS, the inverse correlation to TPO was stronger in CFU-meg (CC: −0.678, P < 0.0001) than in platelet counts (CC: −0.538, P = 0.0014), suggesting that CFU-meg plays an important role in regulating TPO production in this heterogenous disorder. CFU-meg and TPO may provide useful information for understanding thrombopoiesis of MDS, especially for application of TPO.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vainchenker W, Guichard J, Breton-Gorius J . Growth of human megakaryocyte colonies in culture from fetal, neonatal, and adult peripheral blood cells: ultrastructural analysis Blood Cells 1979 5: 25–42
Hoffman R, Mazur E, Bruno E, Floyd V . Assay of an activity in the serum of patients with disorders of thrombopoiesis that stimulates formation of megakaryocytic colonies New Engl J Med 1981 305: 533–538
Messner HA, Jamal N, Izaguirre C . The growth of large megakaryocyte colonies from human bone marrow J Cell Physiol 1982 : (Suppl. 1) 45–51
Debili N, Wendling F, Cosman D, Titeux M, Florindo C, Dusanter-Fourt I, Schooley K, Methia N, Charon M, Nador R, Bettaieb A, Vainchenker W . The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets Blood 1995 85: 391–401
Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Helpel MD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AFT, Mathewes SL, Bailey MC, Forstrom JW, Buddle MM, Osborn SG, Evans SJ, Sheppard PO, Presnell SR, O'Hara PJ, Hagen FS, Roth GJ, Foster DC . Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo Nature 1994 369: 565–568
Kuter DJ, Beeler DL, Rosenberg RD . The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production Proc Natl Acad Sci USA 1994 91: 11104–11108
Kuter DJ, Rosenberg RD . Appearance of a megakaryocyte growth-promoting activity, megalopoietin, during acute thrombocytopenia in the rabbit Blood 1994 84: 1464–1472
Kuter DJ, Rosenberg RD . The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit Blood 1995 85: 2720–2730
Ulich TR, del Castillo J, Yin S, Swift S, Padilla D, Senaldi G, Bennett L, Shutter J, Bogenberger J, Sun D, Samal B, Shimamoto G, Lee R, Steinbrink R, Boone T, Sheridan WT, Hunt P . Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice Blood 1995 86: 971–976
Stoffel R, Wiestner A, Skoda RC . Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets Blood 1996 87: 567–574
McCarty JM, Sprugel KH, Fox NE, Sabath DE, Kaushansky K . Murine thrombopoietin mRNA levels are modulated by platelet count Blood 1995 86: 3668–3675
Kosugi S, Kurata Y, Tomiyama T, Tahara T, Kato T, Tadokoro S, Shiraga M, Honda S, Kanakura T, Matsuzawa M . Circulating thrombopoietin level in chronic immune thrombocytopenic purpura Br J Haematol 1996 93: 704–706
Emmons RVB, Reid DM, Cohen RL, Meng G, Young NS, Dunbar CE, Shulman NR . Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction Blood 1996 87: 4068–4071
Kuefer MU, Wang WC, Head DR, Wilimas JA, Furman WL, Liu Q, Hornkohl AC, Best DM, Jackson CW . Thrombopoietin level in young patients is related to megakaryocyte frequency and platelet count J Pediatr Hematol Oncol 1998 20: 36–43
Hou M, Andersson PO, Stockelberg D, Mellqvist UH, Ridell B, Wadenvik H . Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes Br J Haematol 1998 101: 420–424
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposals for the classification of the myelodysplastic syndromes Br J Haematol 1982 51: 189–199
Dan K, Gomi S, Nomura T . Kinetics of megakaryocyte progenitor cells in idiopathic thrombocytopenic purpura Blut 1990 61: 303–306
Dan K, An E, Futaki M, Inokuchi K, Gomi S, Yamada T, Ogata K, Tanabe Y, Ohki I, Shinohara T, Nomura T . Megakaryocyte, erythroid and granulocyte–macrophage colony formation in myelodysplastic syndromes Acta Haematol 1993 89: 113–118
Abgrall JF, El-Kassar N, Berthou C, Renard I, Cauvin JM, Le Pailleur A, Autrand C, Sensebe L, Guern G, Zilliken P, Le Gall G, Briere J . In vitro megakaryocyte colony formation in patients with idiopathic thrombocytopenic purpura: differences between acute and chronic ITP Int J Cell Cloning 1992 10: 28–32
Abgrall JF, Berthou C, Sensebe L, Le Niger C, Escoffre M . Decreased in vitro megakaryocyte colony formation in chronic idiopathic thrombocytopenic purpura Br J Haematol 1993 85: 803–804
Sugiyama H, Yagita M, Takahashi T, Nakamura K, Iho S, Hoshino T, Imura H . Megakaryocytopoiesis in idiopathic thrombocytopenic purpura Acta Haematol Japan 1986 50: 119–128
Hiyoyama K, Wada H, Shimura M, Nakasaki T, Katayama N, Nishikawa M, Shiku H, Tahara T, Kato T . Increased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation Blood Coagul Fibrin 1997 8: 345–349
Tahara T, Usuki K, Sato H, Ohashi H, Morita H, Tsumura H, Matsumoto A, Miyazaki H, Urabe A, Kato T . A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders Br J Haematol 1996 93: 783–788
Ichikawa N, Ishida F, Shimodaira S, Tahara T, Kato T, Kitano K . Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anaemia and idiopathic thrombocytopenic purpura Thromb Haemost 1996 76: 156–160
Marsh JCW, Gibson FM, Prue RL, Bowen A, Dunn VT, Hornkohl AC, Nichol JL, Gordon-Smith EC . Serum thrombopoietin levels in patients with aplastic anaemia Br J Haematol 1996 95: 605–610
Hirayama Y, Sakamaki S, Matsunaga T, Kuga T, Kuroda H, Kusakabe T, Sasaki K, Fujiwara K, Kato J, Kogawa K, Koyama R, Niitsu Y . Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cells Blood 1998 92: 46–52
Schrezenmeier H, Griesshammer M, Hornkohl A, Nichol JL, Hecht T, Heimpel H, Kubanek B, Raghavachar A . Thrombopoietin serum levels in patients with aplastic anaemia: correlation with platelet count and persistent elevation in remission Br J Haematol 1998 100: 571–576
Juvonen E, Partanen S, Knuutila S, Ruutu T . Colony formation by megakaryocyte progenitors in myelodysplastic syndromes Eur J Haematol 1989 42: 389–395
Geissler D, Zwierzina H, Pechlaner C, Gaggl S, Schmalzl F, Konwalinka G, Braunsteiner H . Abnormal megakaryopoiesis in patients with myelodysplastic syndromes: analysis of cellular and humoral defects Br J Haematol 1989 73: 29–35
Zwierzina H, Rollinger-Holzinger I, Nuessler V, Herold M, Meng YG . Endogenous serum thrombopoietin concentrations in patients with myelodysplastic syndromes Leukemia 1998 12: 59–64
Tamura H, Ogata K, Luo S, Nakamura K, Yokose N, Dan K, Tohyama K, Yoshida Y, Hamaguchi H, Sakamaki H, Kuwaki T, Tahara T, Kato T, Nomura T . Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromes Br J Haematol 1998 103: 778–784
Shivdasani RA, Rosenblatt MF, Zucker-Franklin D, Jackson CW, Hunt P, Saris CJM, Orkin H . Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietion/MGDF in megakaryocyte development Cell 1995 81: 695–704
Guerriero A, Worford L, Holland HK, Guo G-R, Sheehan K, Waller EK . Thrombopoietin is synthesized by bone marrow stromal cells Blood 1997 90: 444–455
Acknowledgements
The authors are grateful to Mr Shigehiro Nakashima for his technical assistance.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, W., Matsuo, T., Yoshida, S. et al. Colony-forming unit-megakaryocyte (CFU-meg) numbers and serum thrombopoietin concentrations in thrombocytopenic disorders: an inverse correlation in myelodysplastic syndromes. Leukemia 14, 1751–1756 (2000). https://doi.org/10.1038/sj.leu.2401898
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401898